Pharma & Healthcare

Global PDE-4 Inhibitors Market Research Report 2025

Report Scope
This report aims to provide a comprehensive presentation of the global market for PDE-4 Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PDE-4 Inhibitors.
The PDE-4 Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PDE-4 Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PDE-4 Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Amgen
Pfizer
AstraZeneca
Anacor Pharmaceuticals
Glenmark Pharmaceuticals
Bristol Myers Squibb
OriFarm
Kohl Medical
Paranova
Torrent Pharmaceuticals
Arcutis Biotherapeutics
MSN Laboratories
Viatris
CSPC Ouyi Pharmaceutical
Segment by Type
Apremilast
Crisaborole
Roflumilast
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PDE-4 Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PDE-4 Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 PDE-4 Inhibitors Market Overview
1.1 Product Definition
1.2 PDE-4 Inhibitors by Type
1.2.1 Global PDE-4 Inhibitors Market Value Comparison by Type (2024 VS 2031)
1.2.2 Apremilast
1.2.3 Crisaborole
1.2.4 Roflumilast
1.2.5 Others
1.3 PDE-4 Inhibitors by Application
1.3.1 Global PDE-4 Inhibitors Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global PDE-4 Inhibitors Market Size Estimates and Forecasts
1.4.1 Global PDE-4 Inhibitors Revenue 2020-2031
1.4.2 Global PDE-4 Inhibitors Sales 2020-2031
1.4.3 Global PDE-4 Inhibitors Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 PDE-4 Inhibitors Market Competition by Manufacturers
2.1 Global PDE-4 Inhibitors Sales Market Share by Manufacturers (2020-2025)
2.2 Global PDE-4 Inhibitors Revenue Market Share by Manufacturers (2020-2025)
2.3 Global PDE-4 Inhibitors Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of PDE-4 Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of PDE-4 Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PDE-4 Inhibitors, Product Type & Application
2.7 Global Key Manufacturers of PDE-4 Inhibitors, Date of Enter into This Industry
2.8 Global PDE-4 Inhibitors Market Competitive Situation and Trends
2.8.1 Global PDE-4 Inhibitors Market Concentration Rate
2.8.2 The Global 5 and 10 Largest PDE-4 Inhibitors Players Market Share by Revenue
2.8.3 Global PDE-4 Inhibitors Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global PDE-4 Inhibitors Market Scenario by Region
3.1 Global PDE-4 Inhibitors Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global PDE-4 Inhibitors Sales by Region: 2020-2031
3.2.1 Global PDE-4 Inhibitors Sales by Region: 2020-2025
3.2.2 Global PDE-4 Inhibitors Sales by Region: 2026-2031
3.3 Global PDE-4 Inhibitors Revenue by Region: 2020-2031
3.3.1 Global PDE-4 Inhibitors Revenue by Region: 2020-2025
3.3.2 Global PDE-4 Inhibitors Revenue by Region: 2026-2031
3.4 North America PDE-4 Inhibitors Market Facts & Figures by Country
3.4.1 North America PDE-4 Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America PDE-4 Inhibitors Sales by Country (2020-2031)
3.4.3 North America PDE-4 Inhibitors Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe PDE-4 Inhibitors Market Facts & Figures by Country
3.5.1 Europe PDE-4 Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe PDE-4 Inhibitors Sales by Country (2020-2031)
3.5.3 Europe PDE-4 Inhibitors Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PDE-4 Inhibitors Market Facts & Figures by Region
3.6.1 Asia Pacific PDE-4 Inhibitors Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific PDE-4 Inhibitors Sales by Region (2020-2031)
3.6.3 Asia Pacific PDE-4 Inhibitors Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America PDE-4 Inhibitors Market Facts & Figures by Country
3.7.1 Latin America PDE-4 Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America PDE-4 Inhibitors Sales by Country (2020-2031)
3.7.3 Latin America PDE-4 Inhibitors Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa PDE-4 Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa PDE-4 Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa PDE-4 Inhibitors Sales by Country (2020-2031)
3.8.3 Middle East and Africa PDE-4 Inhibitors Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PDE-4 Inhibitors Sales by Type (2020-2031)
4.1.1 Global PDE-4 Inhibitors Sales by Type (2020-2025)
4.1.2 Global PDE-4 Inhibitors Sales by Type (2026-2031)
4.1.3 Global PDE-4 Inhibitors Sales Market Share by Type (2020-2031)
4.2 Global PDE-4 Inhibitors Revenue by Type (2020-2031)
4.2.1 Global PDE-4 Inhibitors Revenue by Type (2020-2025)
4.2.2 Global PDE-4 Inhibitors Revenue by Type (2026-2031)
4.2.3 Global PDE-4 Inhibitors Revenue Market Share by Type (2020-2031)
4.3 Global PDE-4 Inhibitors Price by Type (2020-2031)
5 Segment by Application
5.1 Global PDE-4 Inhibitors Sales by Application (2020-2031)
5.1.1 Global PDE-4 Inhibitors Sales by Application (2020-2025)
5.1.2 Global PDE-4 Inhibitors Sales by Application (2026-2031)
5.1.3 Global PDE-4 Inhibitors Sales Market Share by Application (2020-2031)
5.2 Global PDE-4 Inhibitors Revenue by Application (2020-2031)
5.2.1 Global PDE-4 Inhibitors Revenue by Application (2020-2025)
5.2.2 Global PDE-4 Inhibitors Revenue by Application (2026-2031)
5.2.3 Global PDE-4 Inhibitors Revenue Market Share by Application (2020-2031)
5.3 Global PDE-4 Inhibitors Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Company Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen PDE-4 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amgen PDE-4 Inhibitors Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer PDE-4 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer PDE-4 Inhibitors Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca PDE-4 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca PDE-4 Inhibitors Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Anacor Pharmaceuticals
6.4.1 Anacor Pharmaceuticals Company Information
6.4.2 Anacor Pharmaceuticals Description and Business Overview
6.4.3 Anacor Pharmaceuticals PDE-4 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Anacor Pharmaceuticals PDE-4 Inhibitors Product Portfolio
6.4.5 Anacor Pharmaceuticals Recent Developments/Updates
6.5 Glenmark Pharmaceuticals
6.5.1 Glenmark Pharmaceuticals Company Information
6.5.2 Glenmark Pharmaceuticals Description and Business Overview
6.5.3 Glenmark Pharmaceuticals PDE-4 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Glenmark Pharmaceuticals PDE-4 Inhibitors Product Portfolio
6.5.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.6 Bristol Myers Squibb
6.6.1 Bristol Myers Squibb Company Information
6.6.2 Bristol Myers Squibb Description and Business Overview
6.6.3 Bristol Myers Squibb PDE-4 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bristol Myers Squibb PDE-4 Inhibitors Product Portfolio
6.6.5 Bristol Myers Squibb Recent Developments/Updates
6.7 OriFarm
6.7.1 OriFarm Company Information
6.7.2 OriFarm Description and Business Overview
6.7.3 OriFarm PDE-4 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.7.4 OriFarm PDE-4 Inhibitors Product Portfolio
6.7.5 OriFarm Recent Developments/Updates
6.8 Kohl Medical
6.8.1 Kohl Medical Company Information
6.8.2 Kohl Medical Description and Business Overview
6.8.3 Kohl Medical PDE-4 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Kohl Medical PDE-4 Inhibitors Product Portfolio
6.8.5 Kohl Medical Recent Developments/Updates
6.9 Paranova
6.9.1 Paranova Company Information
6.9.2 Paranova Description and Business Overview
6.9.3 Paranova PDE-4 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Paranova PDE-4 Inhibitors Product Portfolio
6.9.5 Paranova Recent Developments/Updates
6.10 Torrent Pharmaceuticals
6.10.1 Torrent Pharmaceuticals Company Information
6.10.2 Torrent Pharmaceuticals Description and Business Overview
6.10.3 Torrent Pharmaceuticals PDE-4 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Torrent Pharmaceuticals PDE-4 Inhibitors Product Portfolio
6.10.5 Torrent Pharmaceuticals Recent Developments/Updates
6.11 Arcutis Biotherapeutics
6.11.1 Arcutis Biotherapeutics Company Information
6.11.2 Arcutis Biotherapeutics Description and Business Overview
6.11.3 Arcutis Biotherapeutics PDE-4 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Arcutis Biotherapeutics PDE-4 Inhibitors Product Portfolio
6.11.5 Arcutis Biotherapeutics Recent Developments/Updates
6.12 MSN Laboratories
6.12.1 MSN Laboratories Company Information
6.12.2 MSN Laboratories Description and Business Overview
6.12.3 MSN Laboratories PDE-4 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.12.4 MSN Laboratories PDE-4 Inhibitors Product Portfolio
6.12.5 MSN Laboratories Recent Developments/Updates
6.13 Viatris
6.13.1 Viatris Company Information
6.13.2 Viatris Description and Business Overview
6.13.3 Viatris PDE-4 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Viatris PDE-4 Inhibitors Product Portfolio
6.13.5 Viatris Recent Developments/Updates
6.14 CSPC Ouyi Pharmaceutical
6.14.1 CSPC Ouyi Pharmaceutical Company Information
6.14.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.14.3 CSPC Ouyi Pharmaceutical PDE-4 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.14.4 CSPC Ouyi Pharmaceutical PDE-4 Inhibitors Product Portfolio
6.14.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PDE-4 Inhibitors Industry Chain Analysis
7.2 PDE-4 Inhibitors Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PDE-4 Inhibitors Production Mode & Process Analysis
7.4 PDE-4 Inhibitors Sales and Marketing
7.4.1 PDE-4 Inhibitors Sales Channels
7.4.2 PDE-4 Inhibitors Distributors
7.5 PDE-4 Inhibitors Customer Analysis
8 PDE-4 Inhibitors Market Dynamics
8.1 PDE-4 Inhibitors Industry Trends
8.2 PDE-4 Inhibitors Market Drivers
8.3 PDE-4 Inhibitors Market Challenges
8.4 PDE-4 Inhibitors Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global PDE-4 Inhibitors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global PDE-4 Inhibitors Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global PDE-4 Inhibitors Market Competitive Situation by Manufacturers in 2024
Table 4. Global PDE-4 Inhibitors Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global PDE-4 Inhibitors Sales Market Share by Manufacturers (2020-2025)
Table 6. Global PDE-4 Inhibitors Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global PDE-4 Inhibitors Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market PDE-4 Inhibitors Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of PDE-4 Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of PDE-4 Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of PDE-4 Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of PDE-4 Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PDE-4 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PDE-4 Inhibitors as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PDE-4 Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global PDE-4 Inhibitors Sales by Region (2020-2025) & (K Units)
Table 18. Global PDE-4 Inhibitors Sales Market Share by Region (2020-2025)
Table 19. Global PDE-4 Inhibitors Sales by Region (2026-2031) & (K Units)
Table 20. Global PDE-4 Inhibitors Sales Market Share by Region (2026-2031)
Table 21. Global PDE-4 Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global PDE-4 Inhibitors Revenue Market Share by Region (2020-2025)
Table 23. Global PDE-4 Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global PDE-4 Inhibitors Revenue Market Share by Region (2026-2031)
Table 25. North America PDE-4 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America PDE-4 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 27. North America PDE-4 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 28. North America PDE-4 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America PDE-4 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe PDE-4 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe PDE-4 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 32. Europe PDE-4 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 33. Europe PDE-4 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe PDE-4 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific PDE-4 Inhibitors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific PDE-4 Inhibitors Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific PDE-4 Inhibitors Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific PDE-4 Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific PDE-4 Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America PDE-4 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America PDE-4 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 42. Latin America PDE-4 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 43. Latin America PDE-4 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America PDE-4 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa PDE-4 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa PDE-4 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa PDE-4 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa PDE-4 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa PDE-4 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global PDE-4 Inhibitors Sales (K Units) by Type (2020-2025)
Table 51. Global PDE-4 Inhibitors Sales (K Units) by Type (2026-2031)
Table 52. Global PDE-4 Inhibitors Sales Market Share by Type (2020-2025)
Table 53. Global PDE-4 Inhibitors Sales Market Share by Type (2026-2031)
Table 54. Global PDE-4 Inhibitors Revenue (US$ Million) by Type (2020-2025)
Table 55. Global PDE-4 Inhibitors Revenue (US$ Million) by Type (2026-2031)
Table 56. Global PDE-4 Inhibitors Revenue Market Share by Type (2020-2025)
Table 57. Global PDE-4 Inhibitors Revenue Market Share by Type (2026-2031)
Table 58. Global PDE-4 Inhibitors Price (US$/Unit) by Type (2020-2025)
Table 59. Global PDE-4 Inhibitors Price (US$/Unit) by Type (2026-2031)
Table 60. Global PDE-4 Inhibitors Sales (K Units) by Application (2020-2025)
Table 61. Global PDE-4 Inhibitors Sales (K Units) by Application (2026-2031)
Table 62. Global PDE-4 Inhibitors Sales Market Share by Application (2020-2025)
Table 63. Global PDE-4 Inhibitors Sales Market Share by Application (2026-2031)
Table 64. Global PDE-4 Inhibitors Revenue (US$ Million) by Application (2020-2025)
Table 65. Global PDE-4 Inhibitors Revenue (US$ Million) by Application (2026-2031)
Table 66. Global PDE-4 Inhibitors Revenue Market Share by Application (2020-2025)
Table 67. Global PDE-4 Inhibitors Revenue Market Share by Application (2026-2031)
Table 68. Global PDE-4 Inhibitors Price (US$/Unit) by Application (2020-2025)
Table 69. Global PDE-4 Inhibitors Price (US$/Unit) by Application (2026-2031)
Table 70. Amgen Company Information
Table 71. Amgen Description and Business Overview
Table 72. Amgen PDE-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Amgen PDE-4 Inhibitors Product
Table 74. Amgen Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer PDE-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Pfizer PDE-4 Inhibitors Product
Table 79. Pfizer Recent Developments/Updates
Table 80. AstraZeneca Company Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca PDE-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. AstraZeneca PDE-4 Inhibitors Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. Anacor Pharmaceuticals Company Information
Table 86. Anacor Pharmaceuticals Description and Business Overview
Table 87. Anacor Pharmaceuticals PDE-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Anacor Pharmaceuticals PDE-4 Inhibitors Product
Table 89. Anacor Pharmaceuticals Recent Developments/Updates
Table 90. Glenmark Pharmaceuticals Company Information
Table 91. Glenmark Pharmaceuticals Description and Business Overview
Table 92. Glenmark Pharmaceuticals PDE-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Glenmark Pharmaceuticals PDE-4 Inhibitors Product
Table 94. Glenmark Pharmaceuticals Recent Developments/Updates
Table 95. Bristol Myers Squibb Company Information
Table 96. Bristol Myers Squibb Description and Business Overview
Table 97. Bristol Myers Squibb PDE-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Bristol Myers Squibb PDE-4 Inhibitors Product
Table 99. Bristol Myers Squibb Recent Developments/Updates
Table 100. OriFarm Company Information
Table 101. OriFarm Description and Business Overview
Table 102. OriFarm PDE-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. OriFarm PDE-4 Inhibitors Product
Table 104. OriFarm Recent Developments/Updates
Table 105. Kohl Medical Company Information
Table 106. Kohl Medical Description and Business Overview
Table 107. Kohl Medical PDE-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Kohl Medical PDE-4 Inhibitors Product
Table 109. Kohl Medical Recent Developments/Updates
Table 110. Paranova Company Information
Table 111. Paranova Description and Business Overview
Table 112. Paranova PDE-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Paranova PDE-4 Inhibitors Product
Table 114. Paranova Recent Developments/Updates
Table 115. Torrent Pharmaceuticals Company Information
Table 116. Torrent Pharmaceuticals Description and Business Overview
Table 117. Torrent Pharmaceuticals PDE-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Torrent Pharmaceuticals PDE-4 Inhibitors Product
Table 119. Torrent Pharmaceuticals Recent Developments/Updates
Table 120. Arcutis Biotherapeutics Company Information
Table 121. Arcutis Biotherapeutics Description and Business Overview
Table 122. Arcutis Biotherapeutics PDE-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Arcutis Biotherapeutics PDE-4 Inhibitors Product
Table 124. Arcutis Biotherapeutics Recent Developments/Updates
Table 125. MSN Laboratories Company Information
Table 126. MSN Laboratories Description and Business Overview
Table 127. MSN Laboratories PDE-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. MSN Laboratories PDE-4 Inhibitors Product
Table 129. MSN Laboratories Recent Developments/Updates
Table 130. Viatris Company Information
Table 131. Viatris Description and Business Overview
Table 132. Viatris PDE-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Viatris PDE-4 Inhibitors Product
Table 134. Viatris Recent Developments/Updates
Table 135. CSPC Ouyi Pharmaceutical Company Information
Table 136. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 137. CSPC Ouyi Pharmaceutical PDE-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. CSPC Ouyi Pharmaceutical PDE-4 Inhibitors Product
Table 139. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. PDE-4 Inhibitors Distributors List
Table 143. PDE-4 Inhibitors Customers List
Table 144. PDE-4 Inhibitors Market Trends
Table 145. PDE-4 Inhibitors Market Drivers
Table 146. PDE-4 Inhibitors Market Challenges
Table 147. PDE-4 Inhibitors Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report


List of Figures
Figure 1. Product Picture of PDE-4 Inhibitors
Figure 2. Global PDE-4 Inhibitors Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global PDE-4 Inhibitors Market Share by Type: 2024 & 2031
Figure 4. Apremilast Product Picture
Figure 5. Crisaborole Product Picture
Figure 6. Roflumilast Product Picture
Figure 7. Others Product Picture
Figure 8. Global PDE-4 Inhibitors Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global PDE-4 Inhibitors Market Share by Application: 2024 & 2031
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global PDE-4 Inhibitors Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global PDE-4 Inhibitors Market Size (2020-2031) & (US$ Million)
Figure 15. Global PDE-4 Inhibitors Sales (2020-2031) & (K Units)
Figure 16. Global PDE-4 Inhibitors Average Price (US$/Unit) & (2020-2031)
Figure 17. PDE-4 Inhibitors Report Years Considered
Figure 18. PDE-4 Inhibitors Sales Share by Manufacturers in 2024
Figure 19. Global PDE-4 Inhibitors Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest PDE-4 Inhibitors Players: Market Share by Revenue in PDE-4 Inhibitors in 2024
Figure 21. PDE-4 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global PDE-4 Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America PDE-4 Inhibitors Sales Market Share by Country (2020-2031)
Figure 24. North America PDE-4 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 25. United States PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe PDE-4 Inhibitors Sales Market Share by Country (2020-2031)
Figure 28. Europe PDE-4 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 29. Germany PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific PDE-4 Inhibitors Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific PDE-4 Inhibitors Revenue Market Share by Region (2020-2031)
Figure 36. China PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America PDE-4 Inhibitors Sales Market Share by Country (2020-2031)
Figure 44. Latin America PDE-4 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 45. Mexico PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Colombia PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa PDE-4 Inhibitors Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa PDE-4 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 51. Turkey PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE PDE-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of PDE-4 Inhibitors by Type (2020-2031)
Figure 55. Global Revenue Market Share of PDE-4 Inhibitors by Type (2020-2031)
Figure 56. Global PDE-4 Inhibitors Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of PDE-4 Inhibitors by Application (2020-2031)
Figure 58. Global Revenue Market Share of PDE-4 Inhibitors by Application (2020-2031)
Figure 59. Global PDE-4 Inhibitors Price (US$/Unit) by Application (2020-2031)
Figure 60. PDE-4 Inhibitors Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies